A biopharmaceutical company that seeks to bridge the “bench-to-bedside” gap between medical research discoveries and patient solutions. We do this by leveraging our strong relationships with research universities and medical centers to license their inventions and technologies with the goal of developing them into products that address diseases with significant unmet medical needs.
Lead Underwriter
Berenberg Capital Markets, LLC, Oppenheimer & Co. Inc.
Co-Managers
Brookline Capital Markets, a division of Arcadia Securities, LLC, Ladenburg Thalmann & Co. Inc., LifeSci Capital, LLC, Roth Capital Partners, Inc
